Not applicableStudy completedNCT01537198What this trial is testingSurveillance of Synagis in Korean Pediatric PatientsWho this might be right forRespiratory Syncytial Virus Infection AbbVie (prior sponsor, Abbott) 618
Large-scale testing (Phase 3)Study completedNCT01006629What this trial is testingPalivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian ChildrenWho this might be right forRespiratory Syncytial Virus InfectionPremature BirthBronchopulmonary Dysplasia+1 more Abbott 100
Testing effectiveness (Phase 2)Study completedNCT04068792What this trial is testingA Two-Part Infant Study for Early Diagnosis of Respiratory Syncytial Virus (RSV) and Evaluation of JNJ-53718678 in RSV Acute Respiratory Tract DiseaseWho this might be right forRespiratory Syncytial Viruses Janssen Research & Development, LLC 22
Not applicableStudy completedNCT07164430What this trial is testingThe Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital TerritoryWho this might be right forRespiratory Syncytial Virus (RSV) InfectionRespiratory Syncytial Virus HospitalizationsRespiratory Syncytial Virus Immunization Nicola Irwin 2,792
Early research (Phase 1)Study completedNCT02114268What this trial is testingEvaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897 in Healthy AdultsWho this might be right forRespiratory Syncytial Virus Infections MedImmune LLC 342
Large-scale testing (Phase 3)Study completedNCT05966090What this trial is testingA Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy AdultsWho this might be right forRespiratory Syncytial VirusesRespiratory Syncytial Virus Infections GlaxoSmithKline 530
Testing effectiveness (Phase 2)Study completedNCT03258502What this trial is testingLearn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) InfectionWho this might be right forRespiratory Syncytial Virus Infections Pfizer 66
Not applicableStudy completedNCT00585481What this trial is testingIncidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian ChildrenWho this might be right forRespiratory Syncytial VirusesRespiratory Tract Infection Abbott 310
Large-scale testing (Phase 3)Study completedNCT05070546What this trial is testingAn Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV InfectionWho this might be right forRespiratory Syncytial Virus Infection Prevention Janssen Vaccines & Prevention B.V. 1,124
Large-scale testing (Phase 3)Study completedNCT01466062What this trial is testingClinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical ConditionsWho this might be right forRespiratory Syncytial Virus Infection AbbVie (prior sponsor, Abbott) 28
Large-scale testing (Phase 3)Ended earlyNCT06079320What this trial is testingLearn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) InfectionWho this might be right forRespiratory Syncytial Virus Infection Pfizer 16
Testing effectiveness (Phase 2)Study completedNCT02979431What this trial is testingDose Ranging Study of ALX-0171 in Infants Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract InfectionWho this might be right forRespiratory Syncytial Virus Lower Respiratory Tract Infection Ablynx, a Sanofi company 180
Large-scale testing (Phase 3)Study completedNCT00014391What this trial is testingRibavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT04090658What this trial is testingTest GlaxoSmithKline's (GSK) Respiratory Syncytial Virus RSV Candidate Vaccine's Safety and Immune Response in Japanese Older AdultsWho this might be right forRespiratory Syncytial Virus Infections GlaxoSmithKline 40
Large-scale testing (Phase 3)Study completedNCT05127434What this trial is testingEvaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of AgeWho this might be right forRespiratory Syncytial Virus ModernaTX, Inc. 36,814
Early research (Phase 1)Study completedNCT04065698What this trial is testingPharmacokinetics and Safety of RV521 FormulationsWho this might be right forRespiratory Syncytial Virus Infections Pfizer 9
Large-scale testing (Phase 3)Study completedNCT00129766What this trial is testingStudy of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk ChildrenWho this might be right forRespiratory Syncytial Virus Infections MedImmune LLC 6,635
Early research (Phase 1)Study completedNCT03596801What this trial is testingEvaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and ChildrenWho this might be right forRSV Infection National Institute of Allergy and Infectious Diseases (NIAID) 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06686654What this trial is testingStudy of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and OlderWho this might be right forHuman Metapneumovirus ImmunizationRespiratory Syncytial Virus Immunization Sanofi Pasteur, a Sanofi Company 1,530
Not applicableNot Yet RecruitingNCT07813481What this trial is testingELderly REspiratory VIral CohortWho this might be right forInfluenza VirusesRespiratory Syncytial Virus (RSV)Severe Acute Respiratory Syndrome Coronavirus 2+5 more Assistance Publique - Hôpitaux de Paris 1,000